Una vez que las vacunas COVID-19 producidas en plataformas de ARN mensajero o de vectores de adenovirus estuvieron disponibles, la incidencia de infecciones por SARS-CoV-2 y, especialmente, las hospitalizaciones en la población altamente vulnerable empezaron a disminuir. Las estrategias de vacunación en España se consensuaron en el Ministerio de Sanidad entre un grupo de profesionales de muy diferentes ámbitos, y fueron ampliamente aceptadas por la población.
This document presents a summary of the recommendations for a multidisciplinary approach to Sudden Cardiac Death (SCD) based on the experiences and academic material presented at the International Sudden Death Symposium held in Costa Rica in September 2024.
Once COVID-19 vaccines produced on messenger RNA or adenovirus vector platforms became available, the incidence of SARS-CoV-2 infections, particularly hospitalizations among the highly vulnerable population, began to decline. The vaccination strategies in Spain were agreed upon within the Ministry of Health among a group of professionals from various fields and were widely accepted by the population.
